Gene delivery using ultrasound contrast agents

Echocardiography

Volumn 18, Issue 4, 2001, Pages 355-361

  Unger, Evan C ^a   Hersh, Evan ^b   Vannan, Mani ^c   McCreery, Thomas ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d ImaRx Therapeutics Inc   (United States)

Author keywords

Gene therapy; Microbubbles; Ultrasound contrast agents

Indexed keywords

DNA; ECHO CONTRAST MEDIUM;

ARTICLE; DRUG RELEASE; GENE EXPRESSION; GENE TARGETING; PRIORITY JOURNAL; SHOCK WAVE; TRANSGENE; ULTRASOUND;

EID: 0034956573     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8175.2001.00355.x     Document Type: Article

References (49)

1. Local and systemic evidence for VEGF production after direct intramyocardial injection with naked DNA encoding for VEGF
2. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
3. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury
4. Gene therapy inhibiting neointimal vascular lesion formation: In vivo transfer of endothelial cell nitric oxide synthase gene
5. Molecular biology and gene transfer in atherosclerosis in the stenting era
6. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
7. Gene therapy for myocardial angiogenesis
8. Review article: Gene therapy in gastroenterology and hepatology
9. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
10. Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound
11. Phase I clinical trials of MRX-115. A new ultrasound contrast agent
12. Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist
13. Metabolic instability of plasmid DNA in the cytosol: A potential barrier to gene transfer
14. Uptake by rat liver and intracellular fate of plasmid DNA complexed with poly-L-lysine or poly-D-lysine
15. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle
16. Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine
17. Regulated expression of a foreign gene targeted to the ischaemic myocardium
18. Direct gene transfer to mouse melanoma by intratumor injection of free DNA
19. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity
20. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery
21. Gene transfer mediated by YKS-220 cationic particles: Convenient and efficient gene delivery
22. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
23. Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity
24. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
25. A novel potent strategy for gene delivery using a single peptide vector as a carrier
26. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: Implication for gene therapy
27. Rac continues searching for cause of gene therapy death
28. Ultrasound enhancement of gene expression and gene delivery using acoustically active carriers
29. Ultrasound enhanced gene expression and gene delivery
30. Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
31. MRX 501: A novel ultrasound contrast agent with therapeutic properties
32. Ultrasound enhancement of gene expression from liposomal transfection
33. Ultrasound enhances gene expression of liposomal transfection
34. Echo-enhancing ('contrast') agents for ultrasound
35. Physics of ultrasound contrast agents
36. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound
37. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective
38. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue
39. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound
40. Therapeutic applications of microbubbles
41. Intravenous antisense administered bound to perfluorocarbon exposed sonicated dextrose albumin microbubbles inhibits stenosis formation following coronary balloon injury
42. Ultrasound power affects uptake of PESDA linked oligonucleotide deposition into myocardial tissue
43. The effect of microbubble gas composition and external ultrasound frequency on the non-invasive enhancement of antisense oligonucleotide delivery to the vascular wall in pigs
44. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles
45. Ultrasound-mediated transfection with cationic gelatin
46. In vivo transfection and gene expression in canine myocardium after intravenous injection of microbubble linked plasmid DNA and exposure to ultrasound